Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 52.4M | 47.5M | 46.4M | 43.2M |
| Cost of revenue | 17.0M | 18.0M | 16.7M | 19.3M |
| Gross profit | 35.5M | 29.4M | 29.8M | 23.9M |
| Operating expense | ||||
| Research & development | 24.2M | 23.2M | 24.2M | 25.4M |
| Selling general and admin | 40.4M | 39.6M | 37.8M | 38.2M |
| Other operating expenses | — | — | — | — |
| Operating income | -29.6M | -33.8M | -32.6M | -40.1M |
| Non operating interest income | ||||
| Income | 2.7M | 3.1M | 3.5M | 3.8M |
| Expense | 2.9M | 3.0M | 2.9M | 2.7M |
| Other income expense | — | 0 | — | -7.2M |
| Pretax income | -29.8M | -33.7M | -32.1M | -46.2M |
| Tax provision | — | — | — | — |
| Net income | -29.8M | -33.7M | -32.1M | -46.2M |
| Basic EPS | -0.2 | -0.2 | -0.2 | -0.3 |
| Diluted EPS | -0.2 | -0.2 | -0.2 | -0.3 |
| Basic average shares | 149.2M | 147.7M | 147.5M | 147.4M |
| Diluted average shares | 149.2M | 147.7M | 147.5M | 147.4M |
| EBITDA | -22.2M | -26.3M | -24.6M | -31.3M |
| Net income from continuing op. | -29.8M | -33.7M | -32.1M | -46.2M |
| Minority interests | -22K | 25K | 26K | 26K |
| Preferred stock dividends | — | — | — | — |